That prior authorization almost always requires: a BMI of 30+ (or 27+ with a condition like Type 2 diabetes, high blood pressure, or high cholesterol), proof you're in a structured weight-management program, and, at the 6-month renewal, documented weight loss of at least 5%
Key Takeaways Physician-led, not a drip bar: every IV session at Perfect B is screened and administered under medical oversight, with personalized formulation rather than a standardized package
PMID: 9467542 Murphy MG, et al
T-cells help the body recognize what is "self" versus "threat." When that signaling becomes dysregulated, inflammation can become noisy
Choose Retatrutide If: Maximum weight loss is the primary goal Previous GLP-1 agonists produced significant nausea (GIP component may help) No specific liver health concerns requiring treatment Tolerance for slightly higher GI side effects during titration Response to dual agonists (like tirzepatide) has been positive Choose Survodutide If: Liver health concerns exist (fatty liver, MASH, elevated liver enzymes) Moderate weight loss goals rather than maximum efficacy priority Interest in potential cardiovascular outcome benefits (CVOT data pending) Preference for a compound with FDA Breakthrough Therapy designation Plans to potentially transition to approved medication once available For most people focused primarily on weight loss, Retatrutide presents the stronger option based on available data
M Representative IHC images for NGAL